Skip to content

Comparison of Intraosseous Anaesthesia Using a Computerized System (QuickSleeper) to Conventional Anesthesia

Comparison of Intraosseous Anaesthesia Using a Computerized System (QuickSleeper) to Conventional Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02084433
Acronym
QUICK
Enrollment
158
Registered
2014-03-12
Start date
2015-01-31
Completion date
2017-02-28
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Caries, Molar Incisor Hypomineralisation

Keywords

MIH of the first permanent molar

Brief summary

The purpose is to compare the efficacy of an intraosseous anaesthesia using a computerized system (QuickSleeper) to a conventional infiltration anesthesia. Our hypothesis is that anesthesia via QuickSleeper system can reduce pain during anesthesia and obtain a more rapid local anesthesia compared to the anesthesia via conventional technique by infiltration. Design: split-mouth design AND parallel-arm design

Detailed description

Local anesthesia is commonly used in oral health care and intra-mucosal infiltration anesthesia is most commonly used by practitioners. Anesthesia may cause children a great deal of anxiety because of the fear of the injection. The latter can be painful if the product is delivered too quickly in the mucosa. Recent developments in the techniques and anesthesia systems allow reducing pain during the injection. In particular, computerized systems (electronically assisted local anesthesia) allow a slow injection limiting pressure. Moreover, these systems look like a pen which prevents the negative impression of the image related to the syringe metal. The intraosseous electronically-assisted anesthesia could be an interesting alternative to conventional infiltration anesthesia by making the act less stressful but also less painful for the child.

Interventions

1 / Anesthesia of periosteum (Articaine 1/100000) 2 / penetration of the needle rotated to the apex 3 / osteocentral injection

PROCEDUREconventional anasthesia

para-apical maxillary and locoregional mandibular (Articaine 1/100000) anaesthesia

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
7 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* split-mouth randomized controlled trial: patients with at least two first permanent molars requiring the same treatment with anesthesia * parallel-arm radnomized controlled trial: patients with first permanent molar requiring treatment with anesthesia * vital pulp * patient did not take any pain medication 48 hours before randomization * non-opposition of the child and two holders of parental participation in the study * Treatments can be conservative treatment or endodontic treatment limited to pulpotomy.

Exclusion criteria

* Patients with periodontal disease (periodontal pockets or tooth mobility) or radiological defects (necrosis, furcation or periapical radiolucency) * Disabled or autistic patients * Patients with cancer, heart disease or sickle cell anemia

Design outcomes

Primary

MeasureTime frameDescription
Pain reported by the patient according to the visual analogue scale (VAS)up to 10 minutesPain reported by the patient according to the visual analogue scale (VAS) will be evaluated at the end of the injection / infiltration. The assessment will concern the insertion of the needle and the injection / infiltration

Secondary

MeasureTime frameDescription
latencyup to 15 minuteslatency (in minutes) evaluated by examining the sensitivity of the sulcus using a probe (an exam will be conducted every minute until the sulcus is insensitive to the probe)
need for additional anesthesia during the treatment1 hour
pain felt during the treatment1 hourneed for additional anesthesia during the treatment; pain felt during the treatment evaluated at the end of treatment according to the VAS

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026